← StockMentionMap
PLSE — Pulse Biosciences, Inc
7 mentions in the last 24 hours · 0.02% of all mentions
Why people talked about PLSE (2026-11-06)
- Pulse Biosciences reported Q3 2026 financial results, with EPS missing estimates and revenue falling short of projections.
- The company announced interim six-month results from its PRECISE-BTN clinical study for treating benign thyroid nodules.
AI summary of 5 headlines and post titles — mention data, not investment advice
| Bluesky | 3 | community |
| RSS Bundle | 2 | news |
| SEC EDGAR 8-K | 2 | filings |
Open the live map →